vimarsana.com
Home
Live Updates
Pfizer Inc.: Pfizer and BioNTech Initiate Rolling Submission
Pfizer Inc.: Pfizer and BioNTech Initiate Rolling Submission
Pfizer Inc.: Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
With pediatric COVID-19 cases surpassing 10 million and at the request of the FDA, the companies have submitted available data on the safety and efficacy of two 3 µg doses as part of a three-dose
Related Keywords
Finland ,
United States ,
Canada ,
Poland ,
United Kingdom ,
Spain ,
American ,
Sylke Maas ,
Fosun Pharma ,
American Academy Of Pediatrics ,
Centers For Disease ,
Linkedin ,
Genentech ,
Drug Administration ,
Bayer Animal Health ,
Exchange Commission ,
Pfizer ,
Youtube ,
Pfizer Inc ,
European Union ,
European Medicines Agency ,
Roche Group ,
Emergency Use Authorization ,
Marketing Authorization Holder ,
Coronavirus Disease ,
Disease Control ,
Prescribing Information ,
Purple Cap ,
Gray Cap ,
Vaccination Providers ,
Caregivers Fact Sheet ,
Orange Cap ,
Breakthroughs That Change Patient ,
Pfizer News ,
Annual Report ,
Looking Information ,
Factors That May Affect Future ,
New Technologies ,
Private Securities Litigation Reform Act ,
Year Ended December ,
State Level Data ,
American Academy ,
Updated January ,
Iontech ,
Nitiate ,
Rolling ,
Submission ,
Emergency ,
Authorization ,
Their ,
Covid ,
Vaccine ,
Children ,
Months ,
Through ,
Tears ,
Following ,
Request ,
Rom ,